Filtering by:
Cervical CancerThe HPV Vaccine: A Powerful Way to Help Prevent 3+ Cancers in Women
World HPV Infection Expert, Anna Guiliano, PhD, says, we may be able to eliminate cervical cancer in the U.S. because we have effective screening tests and guidelines for how often they need to be done, as well as vaccines to prevent the infections that cause damage, called lesions, to cells in the cervix. She offers reminders and tips to parents and adult women and men about how they can protect themselves from all cancers related to HPV.
A World Leader in Infection-Related Cancer Research
Anna Giuliano, PhD, an epidemiology professor and researcher at the Moffitt Cancer Center in Tampa, Florida was awarded the prestigious American Cancer Society Research Professor grant in July 2018 for her expertise and ongoing work cancers caused by the human papillomavirus (HPV).
More Teens Getting HPV Vaccinations
The US Centers for Disease Control and Prevention (CDC) reports that almost half (49%) of teenagers have been fully vaccinated for human papillomavirus (HPV), an increase of 5 percentage points from 2016.
Cervical Cancer Survivor: ‘Don't let fear keep you from going to the doctor.’
Tonya Butler did not have health insurance or a primary care doctor in the fall of 2012 when she was diagnosed with cervical cancer.
What You Need to Know About Testing for Cervical Cancer
During the past several decades, screening – testing for cancer before symptoms develop – has reduced deaths from cervical cancer, as doctors have been able to find cancer early and treat it, or prevent it from developing.
Who Should Get the HPV Vaccination and Why
Vaccinations can protect people from getting the types of HPV that most often cause genital warts and cancer. The vaccinations work best when given to people when they’re young.
HPV Vaccination Rates Low Among Childhood Cancer Survivors
Despite the fact that the HPV vaccine is widely available and can help prevent forms of cancer caused by the virus, most young cancer survivors don’t get vaccinated.
FDA Approves a Biosimilar to Avastin for Cancer Treatment
The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) as the first biosimilar drug for treating cancer. It works the same way as Avastin (bevacizumab).